K A L Bradley1, X Mao2, J A C Case1, G Kang2, D C Shungu2, V Gabbay3. 1. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, 10029-6574 New York, USA. 2. Department of Radiology, Weill Cornell Medical College, New York, USA. 3. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, 10029-6574 New York, USA; Nathan Kline Institute for Psychiatric Research, Orangeburg, USA. Electronic address: vilma.gabbay@mssm.edu.
Abstract
BACKGROUND: Mitochondrial dysfunction has been increasingly examined as a potential pathogenic event in psychiatric disorders, although its role early in the course of major depressive disorder (MDD) is unclear. Therefore, the purpose of this study was to investigate mitochondrial dysfunction in medication-free adolescents with MDD through in vivo measurements of neurometabolites using high-spatial resolution multislice/multivoxel proton magnetic resonance spectroscopy. METHODS: Twenty-three adolescents with MDD and 29 healthy controls, ages 12-20, were scanned at 3T and concentrations of ventricular cerebrospinal fluid lactate, as well as N-acetyl-aspartate (NAA), total creatine (tCr), and total choline (tCho) in the bilateral caudate, putamen, and thalamus were reported. RESULTS: Adolescents with MDD exhibited increased ventricular lactate compared to healthy controls [F(1,41)=6.98, P=0.01]. However, there were no group differences in the other neurometabolites. Dimensional analyses in the depressed group showed no relation between any of the neurometabolites and symptomatology, including anhedonia and fatigue. CONCLUSIONS: Increased ventricular lactate in depressed adolescents suggests mitochondrial dysfunction may be present early in the course of MDD; however it is still not known whether the presence of mitochondrial dysfunction is a trait vulnerability of individuals predisposed to psychopathology or a state feature of the disorder. Therefore, there is a need for larger multimodal studies to clarify these chemical findings in the context of network function.
BACKGROUND:Mitochondrial dysfunction has been increasingly examined as a potential pathogenic event in psychiatric disorders, although its role early in the course of major depressive disorder (MDD) is unclear. Therefore, the purpose of this study was to investigate mitochondrial dysfunction in medication-free adolescents with MDD through in vivo measurements of neurometabolites using high-spatial resolution multislice/multivoxel proton magnetic resonance spectroscopy. METHODS: Twenty-three adolescents with MDD and 29 healthy controls, ages 12-20, were scanned at 3T and concentrations of ventricular cerebrospinal fluid lactate, as well as N-acetyl-aspartate (NAA), total creatine (tCr), and total choline (tCho) in the bilateral caudate, putamen, and thalamus were reported. RESULTS: Adolescents with MDD exhibited increased ventricular lactate compared to healthy controls [F(1,41)=6.98, P=0.01]. However, there were no group differences in the other neurometabolites. Dimensional analyses in the depressed group showed no relation between any of the neurometabolites and symptomatology, including anhedonia and fatigue. CONCLUSIONS: Increased ventricular lactate in depressed adolescents suggests mitochondrial dysfunction may be present early in the course of MDD; however it is still not known whether the presence of mitochondrial dysfunction is a trait vulnerability of individuals predisposed to psychopathology or a state feature of the disorder. Therefore, there is a need for larger multimodal studies to clarify these chemical findings in the context of network function.
Authors: R J Steingard; D A Yurgelun-Todd; J Hennen; J C Moore; C M Moore; K Vakili; A D Young; A Katic; W R Beardslee; P F Renshaw Journal: Biol Psychiatry Date: 2000-12-01 Impact factor: 13.382
Authors: Dana L McMakin; Thomas M Olino; Giovanna Porta; Laura J Dietz; Graham Emslie; Gregory Clarke; Karen Dineen Wagner; Joan R Asarnow; Neal D Ryan; Boris Birmaher; Wael Shamseddeen; Taryn Mayes; Betsy Kennard; Anthony Spirito; Martin Keller; Frances L Lynch; John F Dickerson; David A Brent Journal: J Am Acad Child Adolesc Psychiatry Date: 2012-03-03 Impact factor: 8.829
Authors: Rene Luis Olvera; Sheila C Caetano; Jeffrey A Stanley; Hua-Hsuan Chen; Mark Nicoletti; John P Hatch; Manoela Fonseca; Steven R Pliszka; Jair C Soares Journal: Psychiatry Res Date: 2010-11-30 Impact factor: 3.222
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Josephine Barnes; Gerard R Ridgway; Jonathan Bartlett; Susie M D Henley; Manja Lehmann; Nicola Hobbs; Matthew J Clarkson; David G MacManus; Sebastien Ourselin; Nick C Fox Journal: Neuroimage Date: 2010-06-16 Impact factor: 6.556
Authors: Wen-Jang Chu; Melissa P Delbello; Kelly B Jarvis; Mathew M Norris; Mi-Jung Kim; Wade Weber; Jing-Huei Lee; Stephen M Strakowski; Caleb M Adler Journal: Psychiatry Res Date: 2013-06-27 Impact factor: 3.222
Authors: Sarah E Henderson; Amy R Johnson; Ana I Vallejo; Lev Katz; Edmund Wong; Vilma Gabbay Journal: Front Psychiatry Date: 2013-11-25 Impact factor: 4.157
Authors: Elísabet Alcocer-Gómez; Jessica Núñez-Vasco; Nieves Casas-Barquero; Matthew R Williams; José M Navarro-Pando; Pedro Bullón; Mario D Cordero Journal: CNS Neurosci Ther Date: 2016-05-28 Impact factor: 5.243
Authors: Juliana M Curti; Gustavo R Queiroz; Priscilla F V Pereira; Mayara C Anjos; Karina K M C Flaiban; Júlio A N Lisbôa Journal: Can J Vet Res Date: 2020-04 Impact factor: 1.310
Authors: Benjamin Spurny; Eva Heckova; Rene Seiger; Philipp Moser; Manfred Klöbl; Thomas Vanicek; Marie Spies; Wolfgang Bogner; Rupert Lanzenberger Journal: Front Mol Neurosci Date: 2019-02-14 Impact factor: 5.639
Authors: Miguel A Ortega; Miguel Angel Alvarez-Mon; Cielo García-Montero; Oscar Fraile-Martinez; Luis G Guijarro; Guillermo Lahera; Jorge Monserrat; Paula Valls; Fernando Mora; Roberto Rodríguez-Jiménez; Javier Quintero; Melchor Álvarez-Mon Journal: Metabolites Date: 2022-01-08